PREFERRED TREATMENT FREQUENCY IN PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER

被引:0
|
作者
Fode, Mikkel
Nielsen, Torben
Andersen, Jesper R.
Jakobsen, Henrik
Sonksen, Jens
机构
来源
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词
D O I
10.1016/j.juro.2013.02.281
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
722
引用
收藏
页码:E296 / E297
页数:2
相关论文
共 50 条
  • [1] Preferred treatment frequency in patients receiving androgen deprivation therapy for advanced prostate cancer
    Fode, Mikkel
    Nielsen, Torben K.
    Al-Hamadani, Muhammad
    Andersen, Jesper R.
    Jakobsen, Henrik
    Sonksen, Jens
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 : 28 - 28
  • [2] Preferred treatment frequency in patients receiving androgen deprivation therapy for advanced prostate cancer
    Fode, Mikkel
    Nielsen, Torben K.
    Al-Hamadani, Muhammad
    Andersen, Jesper R.
    Jakobsen, Henrik
    Sonksen, Jens
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (02) : 183 - 188
  • [3] Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
    Di Lorenzo, Giuseppe
    Scafuri, Luca
    Costabile, Ferdinando
    Pepe, Liuba
    Scognamiglio, Anna
    Crocetto, Felice
    Guerra, Germano
    Buonerba, Carlo
    FUTURE SCIENCE OA, 2022, 8 (03):
  • [4] BONE HEALTH IN THE PROSTATE CANCER PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY
    Park, Nam Cheol
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 45 - 45
  • [5] Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer
    Koskderelioglu, Asli
    Gedizlioglu, Muhtesem
    Ceylan, Yasin
    Gunlusoy, Bulent
    Kahyaoglu, Nilden
    NEUROLOGICAL SCIENCES, 2017, 38 (08) : 1445 - 1451
  • [6] Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer
    Asli Koskderelioglu
    Muhtesem Gedizlioglu
    Yasin Ceylan
    Bulent Gunlusoy
    Nilden Kahyaoglu
    Neurological Sciences, 2017, 38 : 1445 - 1451
  • [7] Multimodal therapy for the treatment of fatigue in patients with prostate cancer receiving androgen deprivation therapy and radiation.
    Yennurajalingam, Sriram
    Carmack, Cindy
    Basen-Engquist, Karen
    Reuben, James M.
    Bruera, Eduardo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer
    Hoda, M. Raschid
    Kramer, Mario W.
    Merseburger, Axel S.
    Cronauer, Marcus V.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (01) : 105 - 113
  • [9] Current Approach to Androgen Deprivation Therapy in Patients With Advanced Prostate Cancer
    Heidenreich, Axel
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (11) : 776 - 781
  • [10] Increased Fall Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
    Wu, Fang-Jen
    Sheu, Shiow-Yunn
    Lin, Herng-Ching
    Chung, Shiu-Dong
    UROLOGY, 2016, 95 : 145 - 149